Aldeyra Therapeutics, Inc. ALDX
$1.55
+7.99%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-15 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 4 | 4 | 2026-06-05 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-01 | View → |
| DEF 14A | DEF 14A | 2026-04-27 | View → |
| 8-K | 8-K | 2026-04-20 | View → |
| 8-K | 8-K | 2026-04-01 | View → |
| 4 | 4 | 2026-03-31 | View → |
| 4 | 4 | 2026-03-20 | View → |
| 4 | 4 | 2026-03-19 | View → |
| 8-K | 8-K | 2026-03-17 | View → |
| 10-K | 10-K | 2026-02-27 | View → |
| 8-K | 8-K | 2025-12-31 | View → |
| 8-K | 8-K | 2025-12-16 | View → |
| 8-K | 8-K | 2025-11-13 | View → |
| 10-Q | 10-Q | 2025-11-05 | View → |
| 8-K | 8-K | 2025-10-28 | View → |
| 8-K | 8-K | 2025-08-19 | View → |
| 4 | 4 | 2025-08-15 | View → |
| 4 | 4 | 2025-08-13 | View → |
| 10-Q | 10-Q | 2025-08-07 | View → |
| 8-K | CURRENT REPORT | 2025-07-17 | View → |
| 8-K | CURRENT REPORT | 2025-06-26 | View → |
| 8-K | FORM 8-K | 2025-06-17 | View → |
| 4 | 4 | 2025-06-12 | View → |
| 4 | 4 | 2025-06-12 | View → |
| 4 | 4 | 2025-06-12 | View → |
| 4 | 4 | 2025-06-12 | View → |
| 4 | 4 | 2025-06-12 | View → |
| 4 | 4 | 2025-06-12 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $1.55
- Market Cap
- $91.70 million
- 52-Week Range
- $1.07 – $6.17
- Average Volume
- 1.17 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.